Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Eastwood Bio-Medical Canada Inc. (V:EBM)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
 
Company Contact
Address: 1130 - 4871 Shell Road
RICHMOND BC V6X 3Z6
Tel: N/A
Website: https://eleotin.ca
IR: See website
Key People
Yunji Kim
President, Chief Financial Officer, Corporate Secretary, Director
Youngsoo Kim
Chief Executive Officer, Director
 
Business Overview
Eastwood Bio-Medical Canada Inc. is engaged in marketing and distributing natural health products in North America. It is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients that are presented in tea or capsule forms. The Eleotin products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. Its licensed products include Eleotin A 700, which is a treatment for spleen deficiency, lack of appetite and fatigue; Eleotin AL88, a laxative; Eleotin Cal20, for bone and teeth maintenance; Eleotin V3D, for the development and maintenance of bones, teeth and good health; Eleotin G2000, for cardiovascular health; Eleotin H55, for sedative and tension relief, and Eleotin Zn330, for the tissue formation and metabolism. In addition, it offers Eleotin Bentley to promote healthy glucose levels and Eleotin LBM for hypertension relief.
Financial Overview
For the fiscal year ended 31 October 2023, Eastwood Bio-Medical Canada Inc revenues decreased 33% to C$868K. Net loss increased from C$150K to C$547K. Revenues reflect Asia segment decrease of 34% to C$616K, Canada segment decrease of 45% to C$113K. Higher net loss reflects Wages and Salaries increase of 11% to C$504K (expense), Office increase from C$9K to C$55K (expense). Basic Earnings per Share excluding Extraordinary Items totaled to -C$0.01.
Reporting Currency: Canadian Dollars
Enterprise value: $55.15M as of Oct 31, 2023
Annual revenue (TTM): $0.87M as of Oct 31, 2023
EBITDA (TTM): -$0.43M as of Oct 31, 2023
Net annual income (TTM): -$0.55M as of Oct 31, 2023
Free cash flow (TTM): -$0.02M as of Oct 31, 2023
Net Debt Last Fiscal Year: $0.04M as of Oct 31, 2023
Shares outstanding: 68,885,969 as of Oct 31, 2023
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization